Pieris Pharmaceuticals - 9 Year Stock Price History | PVLA
Historical daily share price chart and data for Pieris Pharmaceuticals since 2015 adjusted for splits and dividends. The latest closing stock price for Pieris Pharmaceuticals as of December 20, 2024 is 12.05.
- The all-time high Pieris Pharmaceuticals stock closing price was 756.00 on February 13, 2018.
- The Pieris Pharmaceuticals 52-week high stock price is 22.32, which is 85.2% above the current share price.
- The Pieris Pharmaceuticals 52-week low stock price is 6.20, which is 48.5% below the current share price.
- The average Pieris Pharmaceuticals stock price for the last 52 weeks is 13.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pieris Pharmaceuticals Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2024 |
13.9371 |
14.8960 |
18.4700 |
6.5300 |
12.0500 |
-17.24% |
2023 |
53.7853 |
87.2000 |
157.6000 |
11.2000 |
14.5600 |
-82.50% |
2022 |
163.0394 |
312.8000 |
312.8000 |
70.4000 |
83.2000 |
-72.49% |
2021 |
277.4921 |
218.4000 |
468.0000 |
140.8000 |
302.4000 |
51.20% |
2020 |
230.1787 |
273.6000 |
339.2000 |
128.8000 |
200.0000 |
-30.94% |
2019 |
300.8127 |
233.6000 |
464.8000 |
201.6000 |
289.6000 |
36.09% |
2018 |
458.6996 |
620.0000 |
756.0000 |
196.8000 |
212.8000 |
-64.77% |
2017 |
340.9221 |
116.8000 |
604.0000 |
116.8000 |
604.0000 |
437.29% |
2016 |
137.6579 |
183.2000 |
192.8000 |
108.4000 |
112.4160 |
-38.64% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.016B |
$0.043B |
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
|